Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream
Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.
Healthcare advocacy in 2025: American Society of Echocardiography reviews a busy year
Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.
FDA finalizes Class I recall for Medtronic catheters
There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.
FDA confirms new recall for Johnson & Johnson heart device over safety concerns
Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.
Integrating prior authorization into clinical workflows cuts costs, speeds up decisions
This utilization management tactic disproportionately affects specialties such as diagnostic radiology, radiation oncology and cardiology.

Radiology Business Management Association urges CMS to permanently allow remote supervision of imaging exams

CMS first started allowing this perk in response to the COVID-19 pandemic, with providers able to oversee exams using real-time audio and visual technology.

FDA updates list of cleared VR, augmented reality devices, with radiology leading the way

The administration has now authorized a total of 69 medical products that incorporate AR/VR since 2015, including 28 in radiology.

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

Walgreens settles opioid case with Baltimore; three lawsuits still pending

Baltimore sued eight companies that it claimed profited off the city’s opioid epidemic. To date, the government has received $402.5 million in settlements.

Radiologists speak during Capitol Hill briefing on key breast imaging legislation

U.S. Rep. Rosa DeLauro, D-Conn., convened the hearing a day before new FDA breast density notification requirements were set to go into effect on Sept. 10.

Nuclear Regulatory Commission warns of medical mishaps stemming from radiopharmaceutical use

NRC estimates that 29 of these “medical events” occurred between 2021 and 2023, with “many” involving new therapeutic radiopharma procedures.

American College of Radiology ‘strongly disagrees’ with making CMS payment model mandatory

The feds see this as a way of increasing specialist engagement in value-based care and bolstering their collaboration with PCPs and Medicare beneficiaries.

Biden administration aims to improve prior authorizations for mental health services

Announced Monday, modifications to the Mental Health Parity and Addiction Equity Act would close loopholes that limit patient access to mental health and addiction treatments.

breast radiologist breast cancer mammography

Breast density notification requirements officially go into effect

Imaging facilities are now required to notify all women about their breast density status after completing a mammogram.

Policy & Regulations

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream

Healthcare advocacy in 2025: American Society of Echocardiography reviews a busy year

FDA finalizes Class I recall for Medtronic catheters

FDA confirms new recall for Johnson & Johnson heart device over safety concerns

Integrating prior authorization into clinical workflows cuts costs, speeds up decisions